Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 7 results for "nicholas piramal"

Piramal aims to be among top 3 in OTC business

Related to : Piramal Enterprises Ltd Piramal Enterprises Ltd BSE 13 Oct 16 | 04:01 PM 1795.00 -49.1 (-2.66%) NSE 13 Oct 16 | 03:59 PM 1792.65 -56.15 (-3.04%) Nandini Piramal Piramal Enterprises aims to be among the top three ... Smart Investor, 1 week ago
Piramal scion Nandini intensifies competition in OTC market Business Standard India, 1 week ago

Kilitch Drugs arm buys land for set up plant in Ethiopia

Kilitch Drugs (India) on Monday informed the exchanges that its unit Kilitch Estro Biotech Plc has acquired land for setting up a pharma plant in Ethiopia. The Bureau of Rural Land and Environmental Protection, Federal Democratic Republic of ...
 Hindu Business Line3 weeks ago

CubeX to host conference on consumer healthcare in Mumbai

It would cover diverse topics such as building mega brands to penetrating unchartered territories, creating multiple touch points for consumers and devising collaborative strategies through multiple stakeholders CubeX, a division of Sorento, in ...
 Express Computer India1 month ago

Not So Special Anymore?

Government of India's great push for pharma SEZs is now facing headwinds due to adverse tax changes like the imposition of MAT and DDT. However, industry experts still believe that SEZs are pivotal to the Make in India initiative By Prathiba Raju ...
 CPhI.cn1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less